Prosecution Insights
Last updated: August 18, 2026

Examiner: BELLAH, JEFFREY LAWRENCE

Tech Center 1600 • Art Units: 1636 1652 1677 1683

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
33
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

10.8%
§101 Eligibility
18.9%
§102 Novelty
32.4%
§103 Obviousness
27.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18362074 METHODS AND COMPOSITIONS USING SINGLE STRAND ANNEALING PROTEINS Non-Final OA 10x Genomics, Inc.
17685033 METHODS AND COMPOSITIONS FOR MODIFYING PRIMARY PROBES IN SITU Final Rejection 10x Genomics, Inc.
18564338 CO-MAPPING TRANSCRIPTIONAL STATES AND PROTEIN HISTOLOGY Non-Final OA Massachusetts Institute of Technology
18277268 SYSTEMS AND METHODS FOR DETECTING MICROORGANISM OR VIRAL LOADED AEROSOLS Non-Final OA Massachusetts Institute of Technology
18494008 Method for Analyzing RNA Non-Final OA Shimadzu Corporation
18547258 HIGH-THROUGHPUT ASSESSMENT OF EXOGENOUS POLYNUCLEOTIDE- OR POLYPEPTIDE-MEDIATED TRANSCRIPTOME PERTURBATIONS Non-Final OA THE GENERAL HOSPITAL CORPORATION
18414085 CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON SEPARATE POLYNUCLEOTIDES FOR METHYLATION DETECTION Non-Final OA Illumina, Inc.
18390322 TRANSITION-METAL CATALYST COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS Non-Final OA Illumina, Inc.
18535222 MOLECULAR DETECTION AND COUNTING USING NANOPORES Non-Final OA Roche Sequencing Solutions, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month